75
Participants
Start Date
October 8, 2007
Primary Completion Date
March 1, 2022
Study Completion Date
March 31, 2022
Letrozole (Femara)
Letrozole 2.5 mg PO a day for 24 weeks
Letrozole; Avastin
Letrozole 2.5 mg PO a day and Avastin 15 mg/kg IV every 3 weeks
Georgetown University Medical Center, Washington D.C.
Georgia Cancer Specialists, Atlanta
University of Chicago Medical Center, Chicago
University of California, San Francisco Comprehensive Cancer Center, San Francisco
University of Alabama at Birmingham, Birmingham
Dana Farber Cancer Institute, Boston
University of of North Carolina at Chapel Hill, Chapel Hill
Collaborators (2)
Genentech, Inc.
INDUSTRY
Breast Cancer Research Foundation
OTHER
University of Alabama at Birmingham
OTHER